Malik Akshat, Mishra Aseem, Chopda Prashant, Singhvi Hitesh, Nair Sudhir, Nair Deepa, Laskar Sarbani Ghosh, Prabhash Kumar, Agarwal Jai Prakash, Chaturvedi Pankaj
Department of Head and Neck Oncology, Tata Memorial Centre, Mumbai, India.
Department of Radiation Oncology, Tata Memorial Centre, Mumbai, India.
Eur Arch Otorhinolaryngol. 2019 Jan;276(1):223-231. doi: 10.1007/s00405-018-5191-1. Epub 2018 Nov 7.
In this study we have tried to analyze the impact of age on various clinico-pathological parameters, treatment completion and subsequent survival in older patients.
This is a retrospective analysis of 140 elderly (> 65 years) patients of oral cancer operated between January 2012 and December 2013. The patients were divided into two groups based upon their age that ≤ 70 years and > 70 years.Association of distribution of various clinico-pathological factors between different groups was assessed by using Chi-square test. Survival analysis was done using Kaplan Meir analysis. Univariate and multivariate analysis were performed.
The two groups had similar distribution of various clinico-pathological factors. Disease free survival for the group ≤ 70 and > 70 years was 37.6 months and 36.4 months (p < 0.594). 13.5% and 7.8% patients > 70 years and ≤ 70 years were either advised or received sub-optimal adjuvant therapy (p < 0.002).
There is no difference distribution of various clinico-pathological factors and survival in patients of oral cancer ≤ 70 and > 70 years of age. Age did not affect survival. Majority of patients could complete the adjuvant therapy advised. Still, significantly more number of patients > 70 years could not receive/complete appropriate adjuvant therapy. Thus treatment needs to be tailored keeping in mind the individual's performance status and the co-morbidities.
在本研究中,我们试图分析年龄对老年患者各种临床病理参数、治疗完成情况及后续生存的影响。
这是一项对2012年1月至2013年12月间接受手术的140例老年(>65岁)口腔癌患者的回顾性分析。根据年龄将患者分为两组,年龄≤70岁和>70岁。采用卡方检验评估不同组间各种临床病理因素分布的相关性。使用Kaplan Meir分析进行生存分析。进行单因素和多因素分析。
两组各种临床病理因素的分布相似。年龄≤70岁组和>70岁组的无病生存期分别为37.6个月和36.4个月(p<0.594)。>70岁和≤70岁的患者中分别有13.5%和7.8%被建议或接受了次优辅助治疗(p<0.002)。
年龄≤70岁和>70岁的口腔癌患者在各种临床病理因素分布及生存方面无差异。年龄不影响生存。大多数患者能够完成建议的辅助治疗。然而,>70岁的患者中仍有显著更多的人无法接受/完成适当的辅助治疗。因此,制定治疗方案时需要考虑个体的身体状况和合并症。